Home > Insider Trading > Filing (0000899243-17-024819)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1629137	Global Blood Therapeutics Inc.	GBT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192591	J Charles Homcy	C/O Global Blood Therapeutics, Inc. 400 East Jamie Court, Suite 101 South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-10-26	54,400	$33.93	83,328	No	4	S	Direct
Common Stock	Disposition	2017-10-27	15,600	$34.09	67,728	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,600	Indirect	By Trust

Footnotes

This transaction was executed in multiple trades at prices ranging from $33.75 to $34.15. The price reported above reflects the weighted average price. The Reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $33.90 to $34.45. The price reported above reflects the weighted average price. The Reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.